ORCL

Oracle Corporation

65
Fundamentals60/ 100
Valuation78/ 100
Upside potential73/ 100
Risk potential19/ 100

ORCL trails on the overall score without a compensating advantage in the available component scores.

TMUS

T-Mobile US, Inc.

69
Fundamentals60/ 100
Valuation82/ 100
Upside potential82/ 100
Risk potential9/ 100

TMUS has the edge over ORCL overall, supported by lower modeled downside and stronger modeled upside.

ORCL Fundamentals

MetricStatus
Healthy
Strong
Weak
Strong

ORCL's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.

TMUS Fundamentals

MetricStatus
Stable
Healthy
Strong
Strong

TMUS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.

ORCL PE Valuation

CHEAPFAIREXPENSIVE19x37x56x74x
CHEAPFAIREXPENSIVE19x37x56x74x
LevelPEPriceVs current
Forward15x$127—
Cheap19x$119-6.8%
Current20x$127—
Fair30x$189+49%
Expensive39x$247+94%

Historical ranges are pointers, not guarantees.

ORCL's PE is in its cheap range at 20x. If earnings grow as analysts expect, today's price would be 15x next year's earnings.

TMUS PE Valuation

CHEAPFAIREXPENSIVE32x65x97x130x
CHEAPFAIREXPENSIVE32x65x97x130x
LevelPEPriceVs current
Forward13x$171—
Current16x$171—
Cheap21x$218+27%
Fair26x$274+60%
Expensive56x$581+240%

Historical ranges are pointers, not guarantees.

TMUS has the edge over ORCL in the historical PE scenario, which offers more potential upside but is not a forecast.

ORCL Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly weakening
Moderate
High

Analysts expect strong earnings and revenue growth for ORCL, but weaker profitability.

TMUS Forward outlook

MetricOutlook
Strongly improving
Strong growth
Growth
Strongly improving
Limited
Moderate

TMUS has the edge over ORCL on the outlook, with more favorable profitability expectations.

ORCL Risk to reward

ScenarioChangePrice
Upside+52%$192.98
Downside-19%$102.46

Calculated from the latest close: $127.11 on Nov 12.

ORCL trails TMUS on modeled risk to reward, with less potential upside relative to its potential downside.

TMUS Risk to reward

ScenarioChangePrice
Upside+41%$240.82
Downside-9%$155.85

Calculated from the latest close: $171.03 on Nov 12.

TMUS has a better modeled risk to reward balance than ORCL, with more potential upside relative to its potential downside.

ORCL Earnings Per Share

Q4 2023: $3.63Q1 2024: $3.80Q2 2024: $3.71Q3 2024: $3.88Q4 2024: $4.09Q1 2025: $4.26Q2 2025: $4.34Q3 2025: $4.32Q4 2025: $5.32Q1 2026: $5.57Q2 2026: $5.83Q3 2026: $6.38Forward: $8.53
Q4 2023: $3.63Q1 2024: $3.80Q2 2024: $3.71Q3 2024: $3.88Q4 2024: $4.09Q1 2025: $4.26Q2 2025: $4.34Q3 2025: $4.32Q4 2025: $5.32Q1 2026: $5.57Q2 2026: $5.83Q3 2026: $6.38Forward: $8.53
QuarterTTM EPSYoY
Forward$8.53+34%
Q3 2026$6.38+48%
Q2 2026$5.83+34%
Q1 2026$5.57+31%
Q4 2025$5.32+30%
Q3 2025$4.32+11%
Q2 2025$4.34+17%
Q1 2025$4.26+12%
Q4 2024$4.09+13%

ORCL has the edge over TMUS on earnings, with more consistent year-over-year improvement.

TMUS Earnings Per Share

Q4 2023: $6.93Q1 2024: $7.35Q2 2024: $7.98Q3 2024: $8.77Q4 2024: $9.66Q1 2025: $10.24Q2 2025: $10.59Q3 2025: $10.39Q4 2025: $9.72Q1 2026: $9.41Q2 2026: $9.56Q3 2026: $10.37Forward: $13.49
Q4 2023: $6.93Q1 2024: $7.35Q2 2024: $7.98Q3 2024: $8.77Q4 2024: $9.66Q1 2025: $10.24Q2 2025: $10.59Q3 2025: $10.39Q4 2025: $9.72Q1 2026: $9.41Q2 2026: $9.56Q3 2026: $10.37Forward: $13.49
QuarterTTM EPSYoY
Forward$13.49+30%
Q3 2026$10.37-0.2%
Q2 2026$9.56-9.7%
Q1 2026$9.41-8.1%
Q4 2025$9.72+0.6%
Q3 2025$10.39+18%
Q2 2025$10.59+33%
Q1 2025$10.24+39%
Q4 2024$9.66+39%

TMUS earned $10.37 per share over the past year, about the same as the year before.

ORCL Quarterly Revenue

Q4 2023: $12.9BQ1 2024: $13.3BQ2 2024: $14.3BQ3 2024: $13.3BQ4 2024: $14.1BQ1 2025: $14.1BQ2 2025: $15.9BQ3 2025: $14.9BQ4 2025: $16.1BQ1 2026: $17.2BQ2 2026: $19.2BQ3 2026: $19.3B
Q4 2023: $12.9BQ1 2024: $13.3BQ2 2024: $14.3BQ3 2024: $13.3BQ4 2024: $14.1BQ1 2025: $14.1BQ2 2025: $15.9BQ3 2025: $14.9BQ4 2025: $16.1BQ1 2026: $17.2BQ2 2026: $19.2BQ3 2026: $19.3B
QuarterRevenueYoY
Q3 2026$19.3B+30%
Q2 2026$19.2B+21%
Q1 2026$17.2B+22%
Q4 2025$16.1B+14%
Q3 2025$14.9B+12%
Q2 2025$15.9B+11%
Q1 2025$14.1B+6.4%
Q4 2024$14.1B+8.6%

ORCL has the edge over TMUS on sales, with stronger typical year-over-year growth.

TMUS Quarterly Revenue

Q4 2023: $20.5BQ1 2024: $19.6BQ2 2024: $19.8BQ3 2024: $20.2BQ4 2024: $21.9BQ1 2025: $20.9BQ2 2025: $21.1BQ3 2025: $22BQ4 2025: $24.3BQ1 2026: $23.1BQ2 2026: $22.8BQ3 2026: $23.6B
Q4 2023: $20.5BQ1 2024: $19.6BQ2 2024: $19.8BQ3 2024: $20.2BQ4 2024: $21.9BQ1 2025: $20.9BQ2 2025: $21.1BQ3 2025: $22BQ4 2025: $24.3BQ1 2026: $23.1BQ2 2026: $22.8BQ3 2026: $23.6B
QuarterRevenueYoY
Q3 2026$23.6B+7.4%
Q2 2026$22.8B+7.9%
Q1 2026$23.1B+11%
Q4 2025$24.3B+11%
Q3 2025$22B+8.9%
Q2 2025$21.1B+6.9%
Q1 2025$20.9B+6.6%
Q4 2024$21.9B+6.8%

TMUS's revenue has grown year over year for 10 quarters in a row: $23.6B last quarter, up 7.4% from the same quarter a year ago.

ORCL Free Cash Flow

Q4 2023: −$937MQ1 2024: $3.8BQ2 2024: $3.3BQ3 2024: $5.1BQ4 2024: −$2.7BQ1 2025: $71MQ2 2025: −$2.9BQ3 2025: −$362MQ4 2025: −$10BQ1 2026: −$11.5BQ2 2026: −$1.9BQ3 2026: −$5.4B
Q4 2023: −$937MQ1 2024: $3.8BQ2 2024: $3.3BQ3 2024: $5.1BQ4 2024: −$2.7BQ1 2025: $71MQ2 2025: −$2.9BQ3 2025: −$362MQ4 2025: −$10BQ1 2026: −$11.5BQ2 2026: −$1.9BQ3 2026: −$5.4B
QuarterFree cash flowYoY
Q3 2026-$5.4B-$5B
Q2 2026-$1.9B+$1.1B
Q1 2026-$11.5B-16275%
Q4 2025-$10B-$7.3B
Q3 2025-$362M-107%
Q2 2025-$2.9B-189%
Q1 2025$71M-98%
Q4 2024-$2.7B-$1.7B

ORCL has burned cash in seven of the last eight quarters: −$28.7B over the past year, against −$5.9B the year before.

TMUS Free Cash Flow

Q4 2023: $3.3BQ1 2024: $2.5BQ2 2024: $3.5BQ3 2024: $4.2BQ4 2024: $3.3BQ1 2025: $4.4BQ2 2025: $4.6BQ3 2025: $4.8BQ4 2025: $4.2BQ1 2026: $4.6BQ2 2026: $4.8BQ3 2026: $5.1B
Q4 2023: $3.3BQ1 2024: $2.5BQ2 2024: $3.5BQ3 2024: $4.2BQ4 2024: $3.3BQ1 2025: $4.4BQ2 2025: $4.6BQ3 2025: $4.8BQ4 2025: $4.2BQ1 2026: $4.6BQ2 2026: $4.8BQ3 2026: $5.1B
QuarterFree cash flowYoY
Q3 2026$5.1B+5.3%
Q2 2026$4.8B+4.4%
Q1 2026$4.6B+4.6%
Q4 2025$4.2B+25%
Q3 2025$4.8B+15%
Q2 2025$4.6B+32%
Q1 2025$4.4B+79%
Q4 2024$3.3B+2%

TMUS has the edge over ORCL on cash generation, producing positive trailing cash flow while its opponent burns cash.

ORCL Total Shares

Q4 2023: 2.8BQ1 2024: 2.8BQ2 2024: 2.8BQ3 2024: 2.9BQ4 2024: 2.9BQ1 2025: 2.9BQ2 2025: 2.9BQ3 2025: 2.9BQ4 2025: 2.9BQ1 2026: 2.9BQ2 2026: 2.9BQ3 2026: 3B
Q4 2023: 2.8BQ1 2024: 2.8BQ2 2024: 2.8BQ3 2024: 2.9BQ4 2024: 2.9BQ1 2025: 2.9BQ2 2025: 2.9BQ3 2025: 2.9BQ4 2025: 2.9BQ1 2026: 2.9BQ2 2026: 2.9BQ3 2026: 3B
PeriodChange %Net change
Quarterly+3%+86M shares
1 year+3.1%+91M shares
3 years+6.3%+177M shares
5 years+4.9%+139M shares
Available history-9.9%-331M shares

ORCL has 3B diluted shares, up 3.1% from a year ago.

TMUS Total Shares

Q4 2023: 1.2BQ1 2024: 1.2BQ2 2024: 1.2BQ3 2024: 1.2BQ4 2024: 1.2BQ1 2025: 1.1BQ2 2025: 1.1BQ3 2025: 1.1BQ4 2025: 1.1BQ1 2026: 1.1BQ2 2026: 1.1BQ3 2026: 1.1B
Q4 2023: 1.2BQ1 2024: 1.2BQ2 2024: 1.2BQ3 2024: 1.2BQ4 2024: 1.2BQ1 2025: 1.1BQ2 2025: 1.1BQ3 2025: 1.1BQ4 2025: 1.1BQ1 2026: 1.1BQ2 2026: 1.1BQ3 2026: 1.1B
PeriodChange %Net change
Quarterly-1%-10.8M shares
1 year-4.9%-55M shares
3 years-8.8%-103M shares
5 years-15%-182M shares
Available history+24%+207M shares

TMUS has the edge over ORCL on shareholder dilution, with a more favorable share count trend.

ORCL Net Leverage

Q4 2023: -0.1xQ1 2024: -0.2xQ2 2024: 4.1xQ3 2024: -0.1xQ4 2024: 0.2xQ1 2025: 0.2xQ2 2025: 3.7xQ3 2025: -0.1xQ4 2025: 0.3xQ1 2026: 0.5xQ2 2026: 3.5xQ3 2026: -0.9x
Q4 2023: -0.1xQ1 2024: -0.2xQ2 2024: 4.1xQ3 2024: -0.1xQ4 2024: 0.2xQ1 2025: 0.2xQ2 2025: 3.7xQ3 2025: -0.1xQ4 2025: 0.3xQ1 2026: 0.5xQ2 2026: 3.5xQ3 2026: -0.9x
QuarterNet LeverageStatus
Q3 2026-0.9xNet Cash
Q2 20263.5xElevated
Q1 20260.5xVery low
Q4 20250.3xVery low
Q3 2025-0.1xNet Cash
Q2 20253.7xElevated
Q1 20250.2xVery low
Q4 20240.2xVery low

ORCL has the edge over TMUS on leverage, with a lower net debt burden relative to earnings.

TMUS Net Leverage

Q4 2023: 2.6xQ1 2024: -0.1xQ2 2024: -0.0xQ3 2024: -0.1xQ4 2024: 2.4xQ1 2025: -0.1xQ2 2025: -0.1xQ3 2025: 0.1xQ4 2025: 2.5xQ1 2026: -0.0xQ2 2026: 0.1xQ3 2026: 0.0x
Q4 2023: 2.6xQ1 2024: -0.1xQ2 2024: -0.0xQ3 2024: -0.1xQ4 2024: 2.4xQ1 2025: -0.1xQ2 2025: -0.1xQ3 2025: 0.1xQ4 2025: 2.5xQ1 2026: -0.0xQ2 2026: 0.1xQ3 2026: 0.0x
QuarterNet LeverageStatus
Q3 20260.0xVery low
Q2 20260.1xVery low
Q1 2026-0.0xNet Cash
Q4 20252.5xModerate
Q3 20250.1xVery low
Q2 2025-0.1xNet Cash
Q1 2025-0.1xNet Cash
Q4 20242.4xModerate

TMUS's net debt is less than a year of its operating earnings (EBITDA).

ORCL Weekly Momentum

MetricValueStatus
RSI41.9Neutral
Stochastic23.0Neutral

ORCL's weekly RSI is 42 (neutral) and its Stochastic is 23 (neutral).

TMUS Weekly Momentum

MetricValueStatus
RSI47.9Neutral
Stochastic42.1Neutral

TMUS's weekly RSI is 48 (neutral) and its Stochastic is 42 (neutral).

ORCL PE vs Technology Sector

MetricORCLSector medianRelative
PE20x28x28% below
PE %28357 pts below

ORCL has the edge over TMUS on valuation relative to its sector.

TMUS PE vs Communication Services Sector

MetricTMUSSector medianRelative
PE16x16xSame PE
PE %12625 pts below

TMUS is trading at 16x earnings, in line with the Communication Services sector's median of 16x.

ORCL Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$131.13.1% below
20 week MA$137.67.7% below
50 week MA$160.321% below
100 week MA$181.430% below
200 week MA$151.916% below

ORCL is in a downtrend: it's below all five of its weekly moving averages, and 16% below its 200-week average.

TMUS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$159.17.5% above
20 week MA$172.00.5% below
50 week MA$187.88.9% below
100 week MA$212.920% below
200 week MA$188.79.4% below

TMUS has the edge over ORCL on trend strength, trading above more of its moving averages.

ORCL Yearly ROI

YearStart priceEnd priceROI
2020$53.5$65.0+22%
2021$65.0$89.7+38%
2022$89.7$80.9-9.9%
2023$80.9$105.4+30%
2024$105.4$169.0+60%
2025$169.0$198.0+17%
2026 YTD$198.0$127.1-36%

ORCL is down 36% so far in 2026, after finishing higher in five of the previous six years.

TMUS Yearly ROI

YearStart priceEnd priceROI
2020$77.2$132.9+72%
2021$132.9$119.9-9.8%
2022$119.9$140.0+17%
2023$140.0$160.3+15%
2024$160.3$223.0+39%
2025$223.0$201.0-9.9%
2026 YTD$201.0$171.0-15%

TMUS has the edge over ORCL on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key